CureVac N.V. (CURX), a biotechnology company focused on mRNA-based therapeutics and vaccines, exhibits robust Shariah compliance. Financial ratios are exceptionally low and meet all major screening standards, with no non-compliant business activities identified. The company is included in all major Shariah indices, affirming its eligibility for Islamic investment portfolios. ESG factors align well with Islamic principles, showing low risk and positive societal impact through healthcare innovation. Overall, CURX presents a high-quality compliant investment opportunity.